INVESTOR ALERT Levi Korsinsky Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and an Upcoming Deadline

BCLI Stock  USD 1.58  0.03  1.86%   
Under 63% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  

Read at newswire.com
news
  

Brainstorm Cell Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

Brainstorm Cell is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

XFORX4 Pharmaceuticals   14.24   
0%
100.0%
CCCCC4 Therapeutics   9.51   
0%
66.0%
ANTXAN2 Therapeutics   4.64   
0%
32.0%
CKPTCheckpoint Therapeutics   2.04   
0%
14.0%
ALDXAldeyra   1.70   
0%
11.0%
EWTXEdgewise Therapeutics   1.29   
0%
9.0%
CELCCelcuity LLC   1.10   
0%
7.0%
PASGPassage Bio   0.32   
0%
2.0%
CRVSCorvus Pharmaceuticals   0.25   
1.0%
0%
MREOMereo BioPharma   0.26   
1.0%
0%
INZYInozyme Pharma   0.34   
2.0%
0%
HOWLWerewolf Therapeutics   0.54   
3.0%
0%
DAWNDay One   0.61   
4.0%
0%
GRIGRI Bio   0.65   
4.0%
0%
GBIOGeneration Bio   0.78   
5.0%
0%
CNTBConnect Biopharma   0.88   
6.0%
0%
PLXProtalix Biotherapeutics   1.64   
11.0%
0%
HCWBHCW Biologics   2.55   
17.0%
0%
TERNTerns Pharmaceuticals   3.03   
21.0%
0%
CUECue Biopharma   4.39   
30.0%
0%
BCABBioatla   4.97   
34.0%
0%
TRVITrevi Therapeutics   6.72   
47.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets